25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Psychemedics Corporation
Buy, Hold or Sell?

Let's analyze Psychemedics together

I guess you are interested in Psychemedics Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Psychemedics Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Psychemedics Corporation

I send you an email if I find something interesting about Psychemedics Corporation.

1. Quick Overview

1.1. Quick analysis of Psychemedics (30 sec.)










1.2. What can you expect buying and holding a share of Psychemedics? (30 sec.)

How much money do you get?

How much money do you get?
$0.14
When do you have the money?
1 year
How often do you get paid?
87.5%

What is your share worth?

Current worth
$0.92
Expected worth in 1 year
$0.59
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
$-0.20
Return On Investment
-7.5%

For what price can you sell your share?

Current Price per Share
$2.67
Expected price per share
$2.07 - $2.895
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Psychemedics (5 min.)




Live pricePrice per Share (EOD)
$2.67
Intrinsic Value Per Share
$1.03 - $10.96
Total Value Per Share
$1.95 - $11.88

2.2. Growth of Psychemedics (5 min.)




Is Psychemedics growing?

Current yearPrevious yearGrowGrow %
How rich?$5.4m$9.3m-$3.3m-55.3%

How much money is Psychemedics making?

Current yearPrevious yearGrowGrow %
Making money-$748.7k-$974.2k$225.5k30.1%
Net Profit Margin-14.9%-17.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Psychemedics (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#107 / 136

Most Revenue
#103 / 136

Most Profit
#61 / 136
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Psychemedics?

Welcome investor! Psychemedics's management wants to use your money to grow the business. In return you get a share of Psychemedics.

First you should know what it really means to hold a share of Psychemedics. And how you can make/lose money.

Speculation

The Price per Share of Psychemedics is $2.67. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Psychemedics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Psychemedics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.92. Based on the TTM, the Book Value Change Per Share is $-0.08 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.03 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Psychemedics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.09-3.4%-0.13-4.8%-0.18-6.7%-0.11-4.0%0.041.4%
Usd Book Value Change Per Share-0.05-1.9%-0.08-3.1%-0.18-6.8%-0.11-4.0%-0.03-1.2%
Usd Dividend Per Share0.000.0%0.031.3%0.083.2%0.082.9%0.114.2%
Usd Total Gains Per Share-0.05-1.9%-0.05-1.9%-0.10-3.6%-0.03-1.1%0.083.0%
Usd Price Per Share2.31-2.66-4.67-5.39-10.98-
Price to Earnings Ratio-6.36--5.39--8.30-8.61--2.09-
Price-to-Total Gains Ratio-46.16-74.67--4.66-14.06-105.96-
Price to Book Ratio2.50-2.59-2.96-2.85-4.61-
Price-to-Total Gains Ratio-46.16-74.67--4.66-14.06-105.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.67
Number of shares374
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.08
Usd Book Value Change Per Share-0.08-0.11
Usd Total Gains Per Share-0.05-0.03
Gains per Quarter (374 shares)-18.78-10.96
Gains per Year (374 shares)-75.12-43.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
151-126-85116-160-54
2101-252-160231-319-98
3152-377-235347-479-142
4203-503-310463-638-186
5253-629-385579-798-230
6304-755-460694-957-274
7355-881-535810-1117-318
8406-1007-610926-1277-362
9456-1132-6851041-1436-406
10507-1258-7601157-1596-450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%23.017.00.057.5%108.020.01.083.7%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%14.026.00.035.0%68.058.03.052.7%
Dividend per Share1.00.03.025.0%8.00.04.066.7%15.00.05.075.0%35.00.05.087.5%106.00.023.082.2%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%8.012.00.040.0%28.012.00.070.0%105.022.02.081.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Psychemedics Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.050-0.084+68%-0.182+264%-0.107+113%-0.031-37%
Book Value Per Share--0.9241.024-10%1.590-42%1.883-51%2.265-59%
Current Ratio--1.5941.530+4%1.578+1%1.979-19%2.353-32%
Debt To Asset Ratio--0.4460.453-2%0.443+1%0.439+2%0.408+9%
Debt To Equity Ratio--0.8060.833-3%0.799+1%0.787+2%0.712+13%
Dividend Per Share---0.034-100%0.085-100%0.077-100%0.112-100%
Enterprise Value--10632202.60012148291.300-12%23361304.191-54%25987469.058-59%59665997.704-82%
Eps---0.091-0.127+40%-0.180+98%-0.108+19%0.038-339%
Ev To Ebitda Ratio---4.467-48.082+976%7.816-157%-6.250+40%-248.838+5470%
Ev To Sales Ratio--0.5140.600-14%1.023-50%1.090-53%1.814-72%
Free Cash Flow Per Share--0.0480.023+105%-0.017+136%-0.015+131%0.114-59%
Free Cash Flow To Equity Per Share---0.002-0.001-48%-0.087+3579%-0.047+1865%0.000-91%
Gross Profit Margin--2.0841.921+8%2.140-3%0.846+146%1.270+64%
Intrinsic Value_10Y_max--10.957--------
Intrinsic Value_10Y_min--1.030--------
Intrinsic Value_1Y_max--0.551--------
Intrinsic Value_1Y_min--0.184--------
Intrinsic Value_3Y_max--2.073--------
Intrinsic Value_3Y_min--0.485--------
Intrinsic Value_5Y_max--4.097--------
Intrinsic Value_5Y_min--0.712--------
Market Cap15738208.200+13%13616202.60015649791.300-13%27534054.191-51%31778419.058-57%64702706.404-79%
Net Profit Margin---0.103-0.149+44%-0.171+66%-0.123+19%-0.007-93%
Operating Margin----0.1170%-0.1990%-0.2030%-0.0540%
Operating Ratio--1.1151.146-3%1.105+1%1.133-2%0.987+13%
Pb Ratio2.890+13%2.5002.587-3%2.956-15%2.846-12%4.606-46%
Pe Ratio-7.354-16%-6.363-5.392-15%-8.301+30%8.606-174%-2.093-67%
Price Per Share2.670+13%2.3102.655-13%4.671-51%5.391-57%10.977-79%
Price To Free Cash Flow Ratio14.052+13%12.15713.437-10%-9.433+178%5.340+128%-3.141+126%
Price To Total Gains Ratio-53.350-16%-46.15774.669-162%-4.659-90%14.064-428%105.960-144%
Quick Ratio--1.2471.231+1%1.332-6%1.655-25%2.068-40%
Return On Assets---0.054-0.067+24%-0.063+15%-0.037-31%0.003-2201%
Return On Equity---0.098-0.123+26%-0.116+18%-0.069-30%0.000-100%
Total Gains Per Share---0.050-0.050+0%-0.097+95%-0.029-41%0.081-162%
Usd Book Value--5446000.0006035000.000-10%9373250.000-42%11097750.000-51%13348934.450-59%
Usd Book Value Change Per Share---0.050-0.084+68%-0.182+264%-0.107+113%-0.031-37%
Usd Book Value Per Share--0.9241.024-10%1.590-42%1.883-51%2.265-59%
Usd Dividend Per Share---0.034-100%0.085-100%0.077-100%0.112-100%
Usd Enterprise Value--10632202.60012148291.300-12%23361304.191-54%25987469.058-59%59665997.704-82%
Usd Eps---0.091-0.127+40%-0.180+98%-0.108+19%0.038-339%
Usd Free Cash Flow--280000.000136750.000+105%-101000.000+136%-85700.000+131%674892.600-59%
Usd Free Cash Flow Per Share--0.0480.023+105%-0.017+136%-0.015+131%0.114-59%
Usd Free Cash Flow To Equity Per Share---0.002-0.001-48%-0.087+3579%-0.047+1865%0.000-91%
Usd Market Cap15738208.200+13%13616202.60015649791.300-13%27534054.191-51%31778419.058-57%64702706.404-79%
Usd Price Per Share2.670+13%2.3102.655-13%4.671-51%5.391-57%10.977-79%
Usd Profit---535000.000-748750.000+40%-974250.000+82%-617100.000+15%232515.250-330%
Usd Revenue--5175000.0005064500.000+2%5700750.000-9%5879100.000-12%7540962.450-31%
Usd Total Gains Per Share---0.050-0.050+0%-0.097+95%-0.029-41%0.081-162%
 EOD+4 -4MRQTTM+25 -14YOY+18 -215Y+17 -2210Y+5 -34

3.3 Fundamental Score

Let's check the fundamental score of Psychemedics Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.354
Price to Book Ratio (EOD)Between0-12.890
Net Profit Margin (MRQ)Greater than0-0.103
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.247
Current Ratio (MRQ)Greater than11.594
Debt to Asset Ratio (MRQ)Less than10.446
Debt to Equity Ratio (MRQ)Less than10.806
Return on Equity (MRQ)Greater than0.15-0.098
Return on Assets (MRQ)Greater than0.05-0.054
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Psychemedics Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.164
Ma 20Greater thanMa 502.453
Ma 50Greater thanMa 1002.374
Ma 100Greater thanMa 2002.294
OpenGreater thanClose2.610
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Psychemedics Corporation

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. The company's testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. It offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas.

Fundamental data was last updated by Penke on 2024-12-16 00:10:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Psychemedics earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Psychemedics to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -10.3% means that $-0.10 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Psychemedics Corporation:

  • The MRQ is -10.3%. The company is making a huge loss. -2
  • The TTM is -14.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-10.3%TTM-14.9%+4.6%
TTM-14.9%YOY-17.1%+2.2%
TTM-14.9%5Y-12.3%-2.6%
5Y-12.3%10Y-0.7%-11.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.3%-2.6%-7.7%
TTM-14.9%-9.1%-5.8%
YOY-17.1%-0.8%-16.3%
5Y-12.3%-3.0%-9.3%
10Y-0.7%-0.7%+0.0%
4.3.1.2. Return on Assets

Shows how efficient Psychemedics is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Psychemedics to the Diagnostics & Research industry mean.
  • -5.4% Return on Assets means that Psychemedics generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Psychemedics Corporation:

  • The MRQ is -5.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.4%TTM-6.7%+1.3%
TTM-6.7%YOY-6.3%-0.4%
TTM-6.7%5Y-3.7%-3.0%
5Y-3.7%10Y0.3%-4.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.4%-1.1%-4.3%
TTM-6.7%-1.7%-5.0%
YOY-6.3%-0.9%-5.4%
5Y-3.7%-0.3%-3.4%
10Y0.3%-0.4%+0.7%
4.3.1.3. Return on Equity

Shows how efficient Psychemedics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Psychemedics to the Diagnostics & Research industry mean.
  • -9.8% Return on Equity means Psychemedics generated $-0.10 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Psychemedics Corporation:

  • The MRQ is -9.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.8%TTM-12.3%+2.5%
TTM-12.3%YOY-11.6%-0.7%
TTM-12.3%5Y-6.9%-5.5%
5Y-6.9%10Y0.0%-6.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.8%0.1%-9.9%
TTM-12.3%-2.1%-10.2%
YOY-11.6%0.3%-11.9%
5Y-6.9%-1.2%-5.7%
10Y0.0%-1.0%+1.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Psychemedics Corporation.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Psychemedics is operating .

  • Measures how much profit Psychemedics makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Psychemedics to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Psychemedics Corporation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-11.7%+11.7%
TTM-11.7%YOY-19.9%+8.2%
TTM-11.7%5Y-20.3%+8.6%
5Y-20.3%10Y-5.4%-14.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--12.7%+12.7%
TTM-11.7%-16.5%+4.8%
YOY-19.9%2.5%-22.4%
5Y-20.3%-1.2%-19.1%
10Y-5.4%2.4%-7.8%
4.3.2.2. Operating Ratio

Measures how efficient Psychemedics is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.11 means that the operating costs are $1.11 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Psychemedics Corporation:

  • The MRQ is 1.115. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.146. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.115TTM1.146-0.031
TTM1.146YOY1.105+0.041
TTM1.1465Y1.133+0.013
5Y1.13310Y0.987+0.146
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1151.211-0.096
TTM1.1461.268-0.122
YOY1.1051.266-0.161
5Y1.1331.206-0.073
10Y0.9871.191-0.204
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Psychemedics Corporation.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Psychemedics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.59 means the company has $1.59 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Psychemedics Corporation:

  • The MRQ is 1.594. The company is able to pay all its short-term debts. +1
  • The TTM is 1.530. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.594TTM1.530+0.064
TTM1.530YOY1.578-0.047
TTM1.5305Y1.979-0.448
5Y1.97910Y2.353-0.374
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5942.169-0.575
TTM1.5302.054-0.524
YOY1.5782.585-1.007
5Y1.9792.646-0.667
10Y2.3533.229-0.876
4.4.3.2. Quick Ratio

Measures if Psychemedics is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Psychemedics to the Diagnostics & Research industry mean.
  • A Quick Ratio of 1.25 means the company can pay off $1.25 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Psychemedics Corporation:

  • The MRQ is 1.247. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.231. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.247TTM1.231+0.016
TTM1.231YOY1.332-0.101
TTM1.2315Y1.655-0.424
5Y1.65510Y2.068-0.413
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2471.239+0.008
TTM1.2311.276-0.045
YOY1.3321.742-0.410
5Y1.6552.042-0.387
10Y2.0682.435-0.367
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Psychemedics Corporation.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Psychemedics assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Psychemedics to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.45 means that Psychemedics assets are financed with 44.6% credit (debt) and the remaining percentage (100% - 44.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Psychemedics Corporation:

  • The MRQ is 0.446. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.453. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.446TTM0.453-0.007
TTM0.453YOY0.443+0.010
TTM0.4535Y0.439+0.014
5Y0.43910Y0.408+0.031
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4460.436+0.010
TTM0.4530.439+0.014
YOY0.4430.360+0.083
5Y0.4390.427+0.012
10Y0.4080.443-0.035
4.5.4.2. Debt to Equity Ratio

Measures if Psychemedics is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Psychemedics to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 80.6% means that company has $0.81 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Psychemedics Corporation:

  • The MRQ is 0.806. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.833. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.806TTM0.833-0.027
TTM0.833YOY0.799+0.034
TTM0.8335Y0.787+0.046
5Y0.78710Y0.712+0.075
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8060.635+0.171
TTM0.8330.659+0.174
YOY0.7990.512+0.287
5Y0.7870.666+0.121
10Y0.7120.717-0.005
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Psychemedics generates.

  • Above 15 is considered overpriced but always compare Psychemedics to the Diagnostics & Research industry mean.
  • A PE ratio of -6.36 means the investor is paying $-6.36 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Psychemedics Corporation:

  • The EOD is -7.354. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.363. Based on the earnings, the company is expensive. -2
  • The TTM is -5.392. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.354MRQ-6.363-0.992
MRQ-6.363TTM-5.392-0.971
TTM-5.392YOY-8.301+2.910
TTM-5.3925Y8.606-13.997
5Y8.60610Y-2.093+10.699
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-7.354-0.217-7.137
MRQ-6.363-0.432-5.931
TTM-5.392-0.693-4.699
YOY-8.301-0.063-8.238
5Y8.6062.176+6.430
10Y-2.0934.721-6.814
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Psychemedics Corporation:

  • The EOD is 14.052. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 12.157. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 13.437. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD14.052MRQ12.157+1.895
MRQ12.157TTM13.437-1.279
TTM13.437YOY-9.433+22.870
TTM13.4375Y5.340+8.097
5Y5.34010Y-3.141+8.481
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD14.052-0.583+14.635
MRQ12.157-1.060+13.217
TTM13.437-1.060+14.497
YOY-9.433-2.360-7.073
5Y5.340-2.193+7.533
10Y-3.141-2.168-0.973
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Psychemedics is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 2.50 means the investor is paying $2.50 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Psychemedics Corporation:

  • The EOD is 2.890. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.500. Based on the equity, the company is underpriced. +1
  • The TTM is 2.587. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.890MRQ2.500+0.390
MRQ2.500TTM2.587-0.087
TTM2.587YOY2.956-0.368
TTM2.5875Y2.846-0.259
5Y2.84610Y4.606-1.760
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.8902.071+0.819
MRQ2.5002.202+0.298
TTM2.5872.192+0.395
YOY2.9562.258+0.698
5Y2.8463.467-0.621
10Y4.6064.078+0.528
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Psychemedics Corporation.

4.8.1. Institutions holding Psychemedics Corporation

Institutions are holding 20.224% of the shares of Psychemedics Corporation.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-3022NW, LP4.68290.534627603416160.5889
2024-09-30Renaissance Technologies Corp4.59520.0009270863139005.4093
2024-09-30Vanguard Group Inc4.263025128300
2024-09-30RBF LLC2.41150.016514214200
2024-06-30BlackRock Inc1.2048071019-5729-7.4647
2024-09-30Wedbush Morgan Securities Inc0.81210.004147868-2473-4.9125
2024-09-30Susquehanna International Group, LLP0.80404739135854310.774
2024-09-30Geode Capital Management, LLC0.7241042679547414.7131
2024-09-30Citadel Advisors Llc0.3649021509886970.1661
2024-09-30Dimensional Fund Advisors, Inc.0.3573021060-1628-7.1756
2024-09-30Santa Monica Partners LP0.33930.02712000000
2024-09-30Northern Trust Corp0.3208018910367424.1139
2024-09-30Morgan Stanley - Brokerage Accounts0.050903001-3001-50
2024-09-30Tower Research Capital LLC0.03350.00011977-1590-44.5753
2024-09-30Advisor Group Holdings, Inc.0.0044025700
2024-09-30CALDWELL SUTTER CAPITAL INC0.00420.000325000
2024-09-30FMR Inc0.00170100-640-86.4865
2024-09-30Bank of America Corp0.00090511230.7692
2024-06-30Royal Bank of Canada0.0008050-12-19.3548
2024-09-30JPMorgan Chase & Co0.0002011-1-8.3333
Total 20.97650.58361236455+54325+4.4%

4.9.2. Funds holding Psychemedics Corporation

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-10-31Vanguard Total Stock Mkt Idx Inv2.8063016541500
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr1.45680.00028586800
2024-10-31Fidelity Extended Market Index0.43720.000225771-578-2.1936
2024-09-30BlackRock U.S. Equity Market F0.15980.00019420-1-0.0106
2024-10-31Fidelity Series Total Market Index0.10520620000
2024-10-31Fidelity Nasdaq Composite Index0.07790.0001459200
2024-11-29Dimensional US Sustainability Core 1 ETF0.07610.0008448800
2024-11-29Dimensional US Core Equity 2 ETF0.0760447700
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.07570.0002446300
2024-09-30NT Ext Equity Mkt Idx Fd - L0.06490.0001382800
2024-09-30Northern Trust Extended Eq Market Idx0.06490.0001382800
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.0610.00023596110.3068
2024-10-31DFA US Core Equity 1 I0.05850345000
2024-10-31Spartan Extended Market Index Pool E0.04620.0001272357826.9464
2024-06-30NT Quality SCC US Fund - L0.04440.00292616-244-8.5315
2024-09-30NT Quality Small Cap Core0.0420.00282478-138-5.2752
2024-10-31T. Rowe Price Total Equity Market Idx0.04030.0002237500
2024-10-31Fidelity Total Market Index0.03260192100
2024-11-30State St US Extended Mkt Indx NL Cl C0.03170.0002187100
2024-10-31Dimensional Global Trgtd Value USD Acc0.03050.0001180050.2786
Total 5.7880.0083341180-367-0.1%

5.3. Insider Transactions

Insiders are holding 23.143% of the shares of Psychemedics Corporation.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-12-12Powell Anderson Capital PartneBUY750002.67
2024-12-10Peter KaminSELL3207082.35
2024-12-10Powell Anderson Capital PartneBUY74732.59
2024-12-03Peter KaminBUY14097122.35
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets9,835
Total Liabilities4,389
Total Stockholder Equity5,446
 As reported
Total Liabilities 4,389
Total Stockholder Equity+ 5,446
Total Assets = 9,835

Assets

Total Assets9,835
Total Current Assets6,047
Long-term Assets3,788
Total Current Assets
Cash And Cash Equivalents 1,405
Net Receivables 3,325
Other Current Assets 1,317
Total Current Assets  (as reported)6,047
Total Current Assets  (calculated)6,047
+/-0
Long-term Assets
Property Plant Equipment 3,195
Long-term Assets Other 593
Long-term Assets  (as reported)3,788
Long-term Assets  (calculated)3,788
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,793
Long-term Liabilities596
Total Stockholder Equity5,446
Total Current Liabilities
Short-term Debt 976
Short Long Term Debt 495
Accounts payable 994
Other Current Liabilities 1,823
Total Current Liabilities  (as reported)3,793
Total Current Liabilities  (calculated)4,288
+/- 495
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt108
Long-term Liabilities  (as reported)596
Long-term Liabilities  (calculated)108
+/- 488
Total Stockholder Equity
Common Stock32
Retained Earnings -18,823
Accumulated Other Comprehensive Income -1,634
Other Stockholders Equity 25,871
Total Stockholder Equity (as reported)5,446
Total Stockholder Equity (calculated)5,446
+/-0
Other
Capital Stock32
Cash and Short Term Investments 1,405
Common Stock Shares Outstanding 5,894
Liabilities and Stockholders Equity 9,835
Net Debt 174
Net Invested Capital 5,941
Net Working Capital 2,254
Property Plant and Equipment Gross 25,102
Short Long Term Debt Total 1,579



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-311991-12-311991-09-301991-06-301991-03-311990-12-311990-09-301990-06-301990-03-311989-09-301989-06-301989-03-311988-12-311988-09-301988-06-301988-03-311987-12-311987-09-30
> Total Assets 
0
0
0
1,000
0
0
0
1,800
0
0
0
0
1,500
2,400
0
0
3,300
3,200
0
0
3,000
3,400
3,700
3,800
4,400
4,700
8,900
9,600
10,300
10,500
11,000
11,100
10,200
10,200
13,600
14,500
15,700
16,600
18,000
18,400
18,900
20,200
19,800
19,600
18,700
17,800
17,700
15,800
14,200
13,017
13,067
12,174
11,058
10,031
10,588
9,910
9,108
8,787
9,762
9,399
8,083
7,959
8,157
7,690
7,267
7,467
7,798
8,713
8,434
9,719
10,108
10,714
11,145
10,912
12,080
12,963
13,261
13,588
14,635
15,363
15,561
15,331
15,843
15,705
12,628
11,126
10,329
10,552
10,602
10,539
11,062
11,422
11,766
11,815
12,474
12,846
13,801
13,015
14,121
14,352
14,121
13,708
14,128
15,064
16,550
18,024
22,701
23,428
24,078
22,920
22,777
23,328
22,363
22,366
23,543
25,929
25,032
25,695
23,628
25,452
26,508
27,729
26,425
26,986
24,974
25,529
25,135
26,784
27,531
25,210
25,776
23,980
24,003
24,380
24,587
23,633
21,552
20,968
20,450
20,478
18,732
17,907
16,386
14,104
13,270
11,152
10,113
9,835
9,83510,11311,15213,27014,10416,38617,90718,73220,47820,45020,96821,55223,63324,58724,38024,00323,98025,77625,21027,53126,78425,13525,52924,97426,98626,42527,72926,50825,45223,62825,69525,03225,92923,54322,36622,36323,32822,77722,92024,07823,42822,70118,02416,55015,06414,12813,70814,12114,35214,12113,01513,80112,84612,47411,81511,76611,42211,06210,53910,60210,55210,32911,12612,62815,70515,84315,33115,56115,36314,63513,58813,26112,96312,08010,91211,14510,71410,1089,7198,4348,7137,7987,4677,2677,6908,1577,9598,0839,3999,7628,7879,1089,91010,58810,03111,05812,17413,06713,01714,20015,80017,70017,80018,70019,60019,80020,20018,90018,40018,00016,60015,70014,50013,60010,20010,20011,10011,00010,50010,3009,6008,9004,7004,4003,8003,7003,4003,000003,2003,300002,4001,50000001,8000001,000000
   > Total Current Assets 
0
0
0
500
0
0
0
1,400
0
0
0
0
600
1,400
0
0
2,400
2,300
0
0
1,800
1,700
1,900
2,000
2,600
3,000
7,200
7,900
8,400
8,400
8,700
8,800
7,500
7,500
10,900
11,700
12,900
13,600
14,500
14,800
15,200
16,100
15,300
15,100
14,100
13,400
13,300
11,700
10,400
9,189
9,373
8,687
7,745
6,522
7,357
6,975
6,411
6,389
7,638
7,388
6,279
6,345
6,716
6,447
5,942
6,268
6,623
7,535
7,326
8,694
9,122
9,765
10,082
9,912
11,094
11,991
12,291
12,532
13,536
14,273
14,455
14,279
12,640
14,745
11,584
10,151
9,428
9,724
9,780
9,590
10,129
10,397
10,585
10,434
10,850
10,897
11,500
10,631
11,514
10,552
9,574
8,992
9,202
9,557
9,956
8,759
9,791
9,876
10,577
9,522
8,796
9,499
8,456
8,361
9,470
12,186
10,854
11,827
10,079
12,376
13,865
15,543
14,381
15,442
13,870
13,473
13,323
13,487
12,851
10,778
9,754
8,831
9,598
10,627
11,736
11,672
10,285
10,525
10,902
10,724
9,964
9,535
8,228
7,872
6,805
6,187
6,011
6,047
6,0476,0116,1876,8057,8728,2289,5359,96410,72410,90210,52510,28511,67211,73610,6279,5988,8319,75410,77812,85113,48713,32313,47313,87015,44214,38115,54313,86512,37610,07911,82710,85412,1869,4708,3618,4569,4998,7969,52210,5779,8769,7918,7599,9569,5579,2028,9929,57410,55211,51410,63111,50010,89710,85010,43410,58510,39710,1299,5909,7809,7249,42810,15111,58414,74512,64014,27914,45514,27313,53612,53212,29111,99111,0949,91210,0829,7659,1228,6947,3267,5356,6236,2685,9426,4476,7166,3456,2797,3887,6386,3896,4116,9757,3576,5227,7458,6879,3739,18910,40011,70013,30013,40014,10015,10015,30016,10015,20014,80014,50013,60012,90011,70010,9007,5007,5008,8008,7008,4008,4007,9007,2003,0002,6002,0001,9001,7001,800002,3002,400001,40060000001,400000500000
       Cash And Cash Equivalents 
0
0
0
400
0
0
0
1,300
0
0
0
0
0
1,000
0
0
1,900
1,700
0
0
1,000
800
800
900
1,000
1,700
5,200
6,000
500
400
700
400
200
200
1,300
700
1,500
600
700
400
600
1,700
30
300
700
500
900
500
900
1,201
1,044
3,349
3,435
2,346
2,810
2,703
3,111
2,735
3,291
3,351
3,649
3,164
3,249
3,082
3,022
2,548
2,370
3,676
3,260
2,069
2,433
3,202
3,353
2,255
1,990
3,039
4,180
3,788
4,232
4,613
6,097
6,310
7,118
6,911
6,630
5,487
4,954
3,616
4,840
3,186
2,674
2,873
3,720
2,719
2,618
3,502
5,564
4,726
4,762
3,663
3,066
2,513
2,729
2,843
3,971
2,209
2,349
2,612
3,612
2,746
2,104
1,722
2,689
2,004
2,280
4,112
3,938
6,869
2,961
5,604
8,165
8,284
7,721
6,016
4,069
3,226
7,097
6,492
7,283
5,331
3,672
1,809
2,833
2,190
2,651
1,968
1,992
2,127
1,790
3,458
4,750
4,380
2,445
1,370
1,964
1,421
1,434
1,405
1,4051,4341,4211,9641,3702,4454,3804,7503,4581,7902,1271,9921,9682,6512,1902,8331,8093,6725,3317,2836,4927,0973,2264,0696,0167,7218,2848,1655,6042,9616,8693,9384,1122,2802,0042,6891,7222,1042,7463,6122,6122,3492,2093,9712,8432,7292,5133,0663,6634,7624,7265,5643,5022,6182,7193,7202,8732,6743,1864,8403,6164,9545,4876,6306,9117,1186,3106,0974,6134,2323,7884,1803,0391,9902,2553,3533,2022,4332,0693,2603,6762,3702,5483,0223,0823,2493,1643,6493,3513,2912,7353,1112,7032,8102,3463,4353,3491,0441,201900500900500700300301,7006004007006001,5007001,3002002004007004005006,0005,2001,7001,0009008008001,000001,7001,900001,000000001,300000400000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,700
4,900
3,923
2,712
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000
2,000
2,000
2,550
3,050
3,575
3,600
3,683
3,717
3,775
3,675
3,875
2,800
200
2,150
0
0
0
1,003
1,006
2,014
2,016
2,017
2,018
2,019
2,020
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,905
3,912
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000003,9123,905000000000000000000000000000002,0202,0192,0182,0172,0162,0141,0061,0030002,1502002,8003,8753,6753,7753,7173,6833,6003,5753,0502,5502,0002,0002,0000000000000000000002,7123,9234,9005,70000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
100
0
0
0
100
0
0
0
0
400
300
0
0
400
400
0
0
600
700
800
900
1,400
900
1,600
1,600
1,400
1,500
1,600
1,700
1,700
1,700
2,700
2,700
2,700
2,900
4,100
4,000
3,800
3,100
4,000
3,600
3,100
3,900
4,500
4,300
3,200
2,576
4,189
3,958
2,988
2,766
3,180
2,846
2,025
2,354
3,124
2,844
1,724
1,975
2,329
2,410
2,150
2,699
3,353
3,036
3,290
3,527
3,562
3,602
3,272
3,380
4,387
4,276
3,196
3,462
4,166
4,739
3,555
3,570
3,876
4,312
3,398
2,742
2,829
3,810
3,016
3,216
4,268
4,336
3,906
4,496
5,056
6,197
5,055
4,851
5,352
5,343
5,475
5,217
5,190
5,294
4,924
5,026
5,776
5,757
5,898
5,321
4,785
5,888
4,379
4,844
5,460
6,272
5,837
3,787
5,825
5,421
4,488
6,062
5,195
8,067
4,829
5,131
4,526
5,171
3,780
3,558
4,586
5,723
5,851
6,539
6,510
6,950
6,794
7,365
7,390
5,756
4,078
4,067
4,010
4,978
3,705
3,896
3,074
3,325
3,3253,0743,8963,7054,9784,0104,0674,0785,7567,3907,3656,7946,9506,5106,5395,8515,7234,5863,5583,7805,1714,5265,1314,8298,0675,1956,0624,4885,4215,8253,7875,8376,2725,4604,8444,3795,8884,7855,3215,8985,7575,7765,0264,9245,2945,1905,2175,4755,3435,3524,8515,0556,1975,0564,4963,9064,3364,2683,2163,0163,8102,8292,7423,3984,3123,8763,5703,5554,7394,1663,4623,1964,2764,3873,3803,2723,6023,5623,5273,2903,0363,3532,6992,1502,4102,3291,9751,7242,8443,1242,3542,0252,8463,1802,7662,9883,9584,1892,5763,2004,3004,5003,9003,1003,6004,0003,1003,8004,0004,1002,9002,7002,7002,7001,7001,7001,7001,6001,5001,4001,6001,6009001,40090080070060000400400003004000000100000100000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
100
0
0
0
0
100
0
0
100
100
200
100
100
300
200
200
6,300
6,400
6,300
6,500
5,300
5,300
6,700
8,000
8,500
9,700
9,300
9,900
10,300
10,800
10,900
10,800
9,800
8,500
7,400
700
1,000
1,031
967
960
926
1,009
953
471
910
963
915
1,194
907
1,206
1,137
954
770
1,021
900
823
776
1,098
1,127
962
908
1,227
1,142
1,077
1,231
1,566
1,363
1,247
928
1,599
1,446
1,372
1,555
348
262
176
917
326
247
169
941
1,200
1,156
1,198
881
1,054
1,401
1,545
823
1,009
979
1,055
769
1,173
1,260
1,038
690
1,017
1,364
1,287
1,061
1,125
1,242
1,266
1,079
1,171
1,293
1,351
1,212
1,197
1,465
1,359
1,067
1,204
1,700
1,824
1,788
1,889
1,496
1,299
914
1,898
2,575
2,754
1,499
1,033
1,722
1,510
1,136
1,088
1,773
1,524
1,136
870
1,503
1,317
1,3171,5038701,1361,5241,7731,0881,1361,5101,7221,0331,4992,7542,5751,8989141,2991,4961,8891,7881,8241,7001,2041,0671,3591,4651,1971,2121,3511,2931,1711,0791,2661,2421,1251,0611,2871,3641,0176901,0381,2601,1737691,0559791,0098231,5451,4011,0548811,1981,1561,2009411692473269171762623481,5551,3721,4461,5999281,2471,3631,5661,2311,0771,1421,2279089621,1271,0987768239001,0217709541,1371,2069071,1949159639104719531,0099269609671,0311,0007007,4008,5009,80010,80010,90010,80010,3009,9009,3009,7008,5008,0006,7005,3005,3006,5006,3006,4006,300200200300100100200100100001000000100000000000000
   > Long-term Assets 
0
0
0
500
0
0
0
400
0
0
0
0
900
1,000
0
0
900
900
0
0
1,200
1,700
1,800
1,800
1,800
1,700
1,700
1,700
1,900
2,100
2,300
2,300
2,700
2,700
2,700
2,800
2,800
3,000
3,500
3,600
3,700
4,100
4,500
4,500
4,600
4,400
4,400
4,100
3,800
3,829
3,693
3,486
3,313
3,510
3,232
2,935
2,697
2,399
2,123
2,011
1,804
1,613
1,442
1,243
1,325
1,199
1,175
1,178
1,107
1,025
986
949
1,063
1,000
986
972
970
1,055
1,099
1,089
1,105
1,052
3,203
960
1,044
975
901
828
823
948
934
1,025
1,181
1,381
1,624
1,949
2,301
2,384
2,607
3,800
4,547
4,716
4,926
5,507
6,594
9,266
12,910
13,551
13,501
13,398
13,980
13,830
13,907
14,005
14,072
13,742
14,178
13,868
13,549
13,076
12,643
12,186
12,044
11,544
11,104
12,056
11,812
13,297
14,680
14,432
16,022
15,149
14,405
13,753
12,851
11,961
11,267
10,443
9,548
9,754
8,768
8,372
8,158
6,232
6,465
4,965
4,102
3,788
3,7884,1024,9656,4656,2328,1588,3728,7689,7549,54810,44311,26711,96112,85113,75314,40515,14916,02214,43214,68013,29711,81212,05611,10411,54412,04412,18612,64313,07613,54913,86814,17813,74214,07214,00513,90713,83013,98013,39813,50113,55112,9109,2666,5945,5074,9264,7164,5473,8002,6072,3842,3011,9491,6241,3811,1811,0259349488238289019751,0449603,2031,0521,1051,0891,0991,0559709729861,0001,0639499861,0251,1071,1781,1751,1991,3251,2431,4421,6131,8042,0112,1232,3992,6972,9353,2323,5103,3133,4863,6933,8293,8004,1004,4004,4004,6004,5004,5004,1003,7003,6003,5003,0002,8002,8002,7002,7002,7002,3002,3002,1001,9001,7001,7001,7001,8001,8001,8001,7001,20000900900001,0009000000400000500000
       Property Plant Equipment 
0
0
0
500
0
0
0
400
0
0
0
0
800
800
0
0
700
700
0
0
900
1,500
1,500
1,400
1,400
1,400
1,300
1,400
1,500
1,700
1,800
2,000
2,200
2,200
2,200
2,300
2,400
2,500
3,000
3,200
3,200
3,600
4,000
4,000
4,200
4,000
3,900
3,700
3,400
3,454
3,335
3,144
2,983
3,197
2,924
2,643
2,362
2,072
1,814
1,718
1,493
1,320
1,165
983
950
842
829
848
861
798
776
742
777
715
700
686
747
832
876
866
815
759
695
654
830
762
677
604
531
658
643
735
1,067
1,212
1,445
1,726
2,063
2,127
2,339
3,490
4,201
4,331
4,489
4,954
6,050
8,593
12,233
12,825
12,740
12,655
13,236
13,071
13,132
13,214
13,259
12,926
13,358
13,055
12,749
12,258
11,811
11,289
11,129
10,644
10,177
11,155
10,919
12,353
13,737
13,496
15,102
14,254
13,517
12,871
12,002
11,078
10,243
9,441
8,697
7,976
7,254
6,682
6,057
5,423
4,889
4,357
3,571
3,195
3,1953,5714,3574,8895,4236,0576,6827,2547,9768,6979,44110,24311,07812,00212,87113,51714,25415,10213,49613,73712,35310,91911,15510,17710,64411,12911,28911,81112,25812,74913,05513,35812,92613,25913,21413,13213,07113,23612,65512,74012,82512,2338,5936,0504,9544,4894,3314,2013,4902,3392,1272,0631,7261,4451,2121,0677356436585316046777628306546957598158668768327476867007157777427767988618488298429509831,1651,3201,4931,7181,8142,0722,3622,6432,9243,1972,9833,1443,3353,4543,4003,7003,9004,0004,2004,0004,0003,6003,2003,2003,0002,5002,4002,3002,2002,2002,2002,0001,8001,7001,5001,4001,3001,4001,4001,4001,5001,50090000700700008008000000400000500000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
374
359
342
330
313
308
291
335
326
310
293
311
293
277
260
375
357
346
330
246
227
210
207
286
286
286
286
223
224
223
224
290
293
2,508
306
214
213
224
224
291
291
291
290
114
169
179
223
238
256
267
310
345
385
437
553
544
672
677
726
761
743
744
759
775
791
813
816
820
813
800
818
832
897
915
900
927
901
893
944
943
936
920
895
14,405
882
849
883
1,024
1,002
851
1,778
1,514
0
2,101
0
0
0
0
0
000002,10101,5141,7788511,0021,02488384988214,4058959209369439448939019279009158978328188008138208168137917757597447437617266776725445534373853453102672562382231791691142902912912912242242132143062,5082932902242232242232862862862862072102272463303463573752602772933112933103263352913083133303423593740000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
200
0
0
0
200
0
0
0
0
900
1,200
0
0
600
500
0
0
400
1,000
1,000
800
900
700
900
700
700
900
800
700
700
700
600
700
1,400
1,600
2,300
2,600
2,200
3,200
2,800
3,100
2,800
2,600
3,200
2,200
2,400
2,404
2,987
2,558
2,332
2,139
2,761
2,469
2,336
2,173
2,698
2,324
1,739
1,952
2,188
2,064
2,156
2,313
2,091
2,614
2,200
2,616
2,080
2,219
2,250
1,605
1,927
2,022
1,757
1,310
1,577
1,664
1,683
1,562
1,741
1,767
2,068
1,383
1,233
1,214
1,308
1,268
1,465
1,535
2,019
1,740
1,925
1,735
2,766
1,824
2,711
2,734
2,898
2,343
2,474
2,990
4,273
5,589
10,112
10,567
11,241
10,452
10,731
11,128
10,689
11,354
11,688
12,026
9,425
9,244
7,207
8,220
7,888
8,558
8,168
8,472
6,227
7,036
6,658
8,764
10,711
9,402
11,852
11,038
11,491
11,568
11,472
9,606
9,309
8,507
8,514
8,756
7,961
7,741
7,259
6,675
6,598
4,871
4,372
4,389
4,3894,3724,8716,5986,6757,2597,7417,9618,7568,5148,5079,3099,60611,47211,56811,49111,03811,8529,40210,7118,7646,6587,0366,2278,4728,1688,5587,8888,2207,2079,2449,42512,02611,68811,35410,68911,12810,73110,45211,24110,56710,1125,5894,2732,9902,4742,3432,8982,7342,7111,8242,7661,7351,9251,7402,0191,5351,4651,2681,3081,2141,2331,3832,0681,7671,7411,5621,6831,6641,5771,3101,7572,0221,9271,6052,2502,2192,0802,6162,2002,6142,0912,3132,1562,0642,1881,9521,7392,3242,6982,1732,3362,4692,7612,1392,3322,5582,9872,4042,4002,2003,2002,6002,8003,1002,8003,2002,2002,6002,3001,6001,4007006007007007008009007007009007009008001,0001,00040000500600001,2009000000200000200000
   > Total Current Liabilities 
0
0
0
100
0
0
0
100
0
0
0
0
900
1,200
0
0
600
400
0
0
500
700
700
600
700
600
800
600
700
900
800
700
700
700
600
700
1,400
1,600
2,300
2,600
2,100
3,200
2,800
3,100
2,900
2,600
3,100
2,200
2,200
2,237
2,819
2,390
2,222
2,029
2,651
2,359
2,336
2,173
2,698
2,324
1,739
1,952
2,188
2,064
2,156
2,313
2,091
2,614
2,200
2,616
2,080
2,219
2,250
1,605
1,927
2,022
1,757
1,310
1,577
1,664
1,683
1,562
1,741
1,767
2,068
1,383
1,233
1,214
1,308
1,268
1,465
1,535
2,019
1,740
1,925
1,735
2,284
1,342
2,229
2,251
2,083
1,528
1,659
2,176
2,958
3,433
4,082
4,055
3,596
3,157
3,786
3,655
3,565
4,146
4,727
5,498
4,495
4,655
3,364
4,550
4,225
5,172
5,088
5,662
4,060
4,371
4,201
4,686
5,835
4,913
3,283
3,342
3,941
4,330
4,648
5,342
5,830
5,324
5,297
6,176
5,718
5,790
5,639
5,385
4,709
4,184
3,749
3,793
3,7933,7494,1844,7095,3855,6395,7905,7186,1765,2975,3245,8305,3424,6484,3303,9413,3423,2834,9135,8354,6864,2014,3714,0605,6625,0885,1724,2254,5503,3644,6554,4955,4984,7274,1463,5653,6553,7863,1573,5964,0554,0823,4332,9582,1761,6591,5282,0832,2512,2291,3422,2841,7351,9251,7402,0191,5351,4651,2681,3081,2141,2331,3832,0681,7671,7411,5621,6831,6641,5771,3101,7572,0221,9271,6052,2502,2192,0802,6162,2002,6142,0912,3132,1562,0642,1881,9521,7392,3242,6982,1732,3362,3592,6512,0292,2222,3902,8192,2372,2002,2003,1002,6002,9003,1002,8003,2002,1002,6002,3001,6001,40070060070070070080090070060080060070060070070050000400600001,2009000000100000100000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
500
700
0
0
200
0
0
0
0
100
100
100
100
100
100
100
200
100
100
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
518
0
661
0
0
0
0
0
0
0
0
0
0
1,158
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
211
1,232
1,400
1,400
1,400
1,400
1,620
1,620
1,742
1,742
1,742
1,144
1,144
542
542
957
957
957
941
416
1,366
1,277
1,587
1,641
1,566
1,573
1,569
1,563
1,654
1,658
1,671
1,648
1,557
1,435
1,345
1,331
1,373
1,366
1,360
2,401
1,273
1,245
976
9761,2451,2732,4011,3601,3661,3731,3311,3451,4351,5571,6481,6711,6581,6541,5631,5691,5731,5661,6411,5871,2771,3664169419579579575425421,1441,1441,7421,7421,7421,6201,6201,4001,4001,4001,4001,2322110000000000000000000000000000000000001,1580000000000661051800000000000000000000000100100100200100100100100100100100000020000700500000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,400
0
0
0
1,620
0
0
0
1,144
1,144
1,605
542
957
957
957
941
416
416
416
416
678
680
683
685
688
691
693
696
664
563
461
360
294
297
299
302
305
230
781
495
4957812303053022992972943604615636646966936916886856836806784164164164169419579579575421,6051,1441,1440001,6200001,400000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
300
0
0
300
300
0
0
300
400
400
300
300
300
400
300
300
500
300
400
500
500
200
300
400
500
700
500
200
600
100
300
700
500
500
300
500
600
489
427
432
540
606
486
376
329
296
338
338
587
540
372
398
627
394
504
554
550
206
402
368
262
347
225
499
228
445
490
489
337
583
434
645
314
353
303
181
283
270
361
700
464
412
294
962
600
1,131
1,267
670
755
577
577
511
779
1,179
683
845
475
590
635
747
1,295
989
1,144
1,363
622
397
1,103
398
327
1,117
813
682
378
704
372
617
1,234
61
416
577
1,109
1,100
448
994
722
598
857
448
785
806
817
752
1,131
662
994
9946621,1317528178067854488575987229944481,1001,109577416611,2346173727043786828131,1173273981,1033976221,3631,1449891,2957476355904758456831,1797795115775777556701,2671,13160096229441246470036127028318130335331464543458333748949044522849922534726236840220655055450439462739837254058733833829632937648660654043242748960050030050050070030010060020050070050040030020050050040030050030030040030030030040040030000300300003000000000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
400
200
0
0
100
100
0
0
200
200
200
200
300
200
300
200
200
300
400
200
200
200
400
400
1,000
1,100
1,600
2,100
1,900
2,600
2,700
2,800
2,200
2,100
2,600
1,900
1,700
1,637
2,330
1,963
1,790
787
1,313
607
1,207
493
1,719
1,314
1,016
964
1,234
1,268
1,326
1,237
1,238
1,641
0
1,563
1,297
1,236
1,292
740
958
1,171
866
721
768
886
951
1,013
965
1,166
1,269
946
821
867
1,091
953
1,173
1,157
1,302
1,262
1,502
1,441
1,322
742
1,098
984
1,414
774
1,082
1,598
2,448
2,444
1,671
1,972
1,351
1,282
1,797
1,400
1,198
1,110
1,996
2,612
1,863
2,889
2,425
2,905
2,792
3,888
3,014
3,908
2,962
2,627
2,220
2,727
3,577
2,113
1,649
1,357
1,801
1,567
1,890
3,223
3,188
3,045
3,264
3,974
3,939
3,632
3,467
3,208
1,003
1,780
1,842
1,823
1,8231,8421,7801,0033,2083,4673,6323,9393,9743,2643,0453,1883,2231,8901,5671,8011,3571,6492,1133,5772,7272,2202,6272,9623,9083,0143,8882,7922,9052,4252,8891,8632,6121,9961,1101,1981,4001,7971,2821,3511,9721,6712,4442,4481,5981,0827741,4149841,0987421,3221,4411,5021,2621,3021,1571,1739531,0918678219461,2691,1669651,0139518867687218661,1719587401,2921,2361,2971,56301,6411,2381,2371,3261,2681,2349641,0161,3141,7194931,2076071,3137871,7901,9632,3301,6371,7001,9002,6002,1002,2002,8002,7002,6001,9002,1001,6001,1001,0004004002002002004003002002003002003002002002002000010010000200400000000000000
   > Long-term Liabilities 
0
0
0
100
0
0
0
100
0
0
0
0
500
1,000
0
0
500
100
0
0
-100
300
300
200
200
100
100
100
500
600
400
500
0
500
200
300
400
500
700
500
100
600
100
300
-100
500
100
300
200
168
168
168
109
109
109
109
1,129
1,019
979
1,010
723
988
955
796
831
1,076
853
973
1,042
1,053
783
983
958
865
970
851
892
589
809
779
732
549
776
600
799
437
412
347
217
315
292
378
716
477
423
294
483
483
483
483
815
815
815
815
1,314
2,157
6,029
6,512
7,645
7,295
6,945
7,474
7,125
7,208
6,962
6,528
4,930
4,589
3,843
3,670
3,663
3,386
3,080
2,810
2,167
2,665
2,457
4,078
4,876
4,489
8,569
7,696
7,550
7,238
6,824
4,264
3,479
3,183
3,217
2,580
2,243
1,951
1,620
1,290
1,889
687
623
596
5966236871,8891,2901,6201,9512,2432,5803,2173,1833,4794,2646,8247,2387,5507,6968,5694,4894,8764,0782,4572,6652,1672,8103,0803,3863,6633,6703,8434,5894,9306,5286,9627,2087,1257,4746,9457,2957,6456,5126,0292,1571,3148158158158154834834834832944234777163782923152173474124377996007765497327798095898928519708659589837831,0531,0429738531,0768317969559887231,0109791,0191,129109109109109168168168200300100500-1003001006001005007005004003002005000500400600500100100100200200300300-10000100500001,0005000000100000100000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
842
4,715
5,198
4,848
4,498
4,148
4,677
4,272
4,355
0
0
2,237
1,951
0
0
2,420
0
1,942
1,719
1,212
1,109
1,005
900
1,951
1,780
0
0
3,444
3,270
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000003,2703,444001,7801,9519001,0051,1091,2121,7191,94202,420001,9512,237004,3554,2724,6774,1484,4984,8485,1984,715842000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,797
0
0
0
2,525
0
0
0
2,693
0
2,780
2,742
1,243
1,205
1,138
1,091
955
907
897
817
550
495
476
0
211
211
238
290
0
0
307
0
0
0
0
0
0
0
0
0
0000000003070029023821121104764955508178979079551,0911,1381,2051,2432,7422,78002,6930002,5250002,797000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
483
483
483
483
815
815
815
815
1,314
1,314
1,314
1,314
2,797
2,797
2,797
2,797
2,853
2,853
0
0
2,693
2,638
0
0
1,243
0
1,138
1,091
737
0
897
817
740
0
0
0
700
211
238
0
700
0
0
0
600
0
0
0
0
0
0
0
0000000600000700023821170000074081789707371,0911,13801,243002,6382,693002,8532,8532,7972,7972,7972,7971,3141,3141,3141,314815815815815483483483483000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
800
0
0
0
1,600
0
0
0
0
600
1,200
0
0
2,700
2,700
0
0
2,600
2,400
2,700
3,000
3,500
4,000
8,000
8,900
9,600
9,600
10,200
10,400
9,500
9,500
13,000
13,800
14,300
15,000
15,700
15,800
16,700
17,000
17,000
16,500
15,900
15,200
14,500
13,600
11,800
10,613
10,080
9,616
8,726
7,893
7,828
7,441
6,772
6,614
7,064
7,075
6,344
6,007
5,969
5,626
5,111
5,154
5,708
6,099
6,234
7,104
8,028
8,494
8,895
9,308
10,153
10,942
11,504
12,277
13,058
13,698
13,878
13,769
14,102
13,938
10,560
9,743
9,095
9,338
9,294
9,271
9,597
9,887
9,748
10,076
10,549
11,111
11,035
11,190
11,410
11,618
11,223
11,365
11,655
12,074
12,277
12,435
12,589
12,860
12,837
12,468
12,046
12,200
11,674
11,012
11,854
13,903
15,607
16,451
16,421
17,232
18,620
19,171
18,257
18,514
18,747
18,493
18,477
18,020
16,820
15,808
13,924
12,942
12,512
12,812
13,115
14,027
12,243
12,461
11,936
11,722
10,771
10,166
9,127
7,429
6,672
6,281
5,741
5,446
5,4465,7416,2816,6727,4299,12710,16610,77111,72211,93612,46112,24314,02713,11512,81212,51212,94213,92415,80816,82018,02018,47718,49318,74718,51418,25719,17118,62017,23216,42116,45115,60713,90311,85411,01211,67412,20012,04612,46812,83712,86012,58912,43512,27712,07411,65511,36511,22311,61811,41011,19011,03511,11110,54910,0769,7489,8879,5979,2719,2949,3389,0959,74310,56013,93814,10213,76913,87813,69813,05812,27711,50410,94210,1539,3088,8958,4948,0287,1046,2346,0995,7085,1545,1115,6265,9696,0076,3447,0757,0646,6146,7727,4417,8287,8938,7269,61610,08010,61311,80013,60014,50015,20015,90016,50017,00017,00016,70015,80015,70015,00014,30013,80013,0009,5009,50010,40010,2009,6009,6008,9008,0004,0003,5003,0002,7002,4002,600002,7002,700001,20060000001,600000800000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
113
113
113
113
113
113
113
113
113
28
28
28
28
28
28
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
32
32
32
32
32
32
32
32
32
32323232323232323231313131313131313131313131313131313131313131313131303030303030303030303030303030303030303029292929292929292929292929292929292929292929292929292929292928282828282811311311311311311311311311310010000000000000000000000000000000000000000000000000
   Retained Earnings Total Equity00000-13,7290000000-8,389-8,523-8,606-8,063-6,956-4,906-3,754-2,232-1,916-1,690-1,326-1,216-1,497-1,685-2,113-3,639-4,179-4,264-4,945-6,486-8,375-9,134-8,297-7,668-7,651-7,095-6,566-6,436-6,546-6,602-6,560-6,631-6,886-7,155-7,186-6,668-6,755-6,967-7,009-6,819-7,2900000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,700
-1,900
-1,900
-2,200
-2,300
-2,400
-2,500
-2,700
-2,900
-3,000
-3,200
-3,500
-3,700
-3,900
-4,300
-4,600
-400
-400
-395
-394
-399
-392
-391
-390
-389
-6,754
-7,053
-7,354
-7,590
-7,829
-8,053
-8,259
-8,445
-8,633
-8,756
-8,873
-8,987
-9,099
-9,203
-9,163
-9,252
-9,343
-9,421
-9,489
-9,559
-9,630
-9,716
-9,803
-9,890
-9,977
-10,062
-10,143
-10,226
-10,048
-10,144
-10,231
-10,308
-10,382
-10,445
-10,505
-10,585
-10,664
-10,747
-10,831
-10,917
-11,026
-11,161
0
-4,222
-4,396
-4,598
-4,804
-5,018
-5,176
-5,368
-5,528
-5,801
-5,789
-6,125
-6,250
-6,538
-6,643
-7,162
-7,695
-8,241
-8,900
-9,577
-71
37
-238
-250
-1,403
-1,584
-1,399
-1,447
-1,365
-1,696
-1,624
-1,647
-1,633
-1,634
-1,634
-1,634
-1,634
-1,634
-1,634
-1,634
-1,634
-1,634
-1,634
-1,634
-1,634
-1,634
-1,634
-1,634
-1,634
-1,634
-1,634-1,634-1,634-1,634-1,634-1,634-1,634-1,634-1,634-1,634-1,634-1,634-1,634-1,634-1,634-1,634-1,634-1,633-1,647-1,624-1,696-1,365-1,447-1,399-1,584-1,403-250-23837-71-9,577-8,900-8,241-7,695-7,162-6,643-6,538-6,250-6,125-5,789-5,801-5,528-5,368-5,176-5,018-4,804-4,598-4,396-4,2220-11,161-11,026-10,917-10,831-10,747-10,664-10,585-10,505-10,445-10,382-10,308-10,231-10,144-10,048-10,226-10,143-10,062-9,977-9,890-9,803-9,716-9,630-9,559-9,489-9,421-9,343-9,252-9,163-9,203-9,099-8,987-8,873-8,756-8,633-8,445-8,259-8,053-7,829-7,590-7,354-7,053-6,754-389-390-391-392-399-394-395-400-400-4,600-4,300-3,900-3,700-3,500-3,200-3,000-2,900-2,700-2,500-2,400-2,300-2,200-1,900-1,900-1,7000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,869
27,982
28,096
28,210
28,217
28,338
28,461
28,572
28,592
28,756
28,889
29,088
29,187
29,347
29,454
29,614
29,748
29,920
30,022
30,197
30,280
30,440
30,603
30,766
30,722
30,885
31,022
31,157
31,208
31,365
31,523
31,681
31,809
31,999
32,249
32,412
32,564
32,690
32,803
33,020
33,189
0
0
0
0
0
0
0
34,540
0
0
0
0
0
0000034,540000000033,18933,02032,80332,69032,56432,41232,24931,99931,80931,68131,52331,36531,20831,15731,02230,88530,72230,76630,60330,44030,28030,19730,02229,92029,74829,61429,45429,34729,18729,08828,88928,75628,59228,57228,46128,33828,21728,21028,09627,98227,8690000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,082-10,059-10,059-10,059-10,053-10,053-10,053-10,053-10,053-10,053-10,053-9,974-9,801-9,545-9,498-9,164-9,164-9,123-9,123-9,123-9,123-9,123-9,123-9,123-9,123-9,123-9,123-9,123-9,123-9,123-9,123-9,123-8,268-7,989-7,969-7,945-7,503-7,503-7,503-7,503-7,079-6,999-6,999-6,999-6,925-6,855-6,4800000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
3,100
0
0
0
4,400
0
0
0
0
6,600
7,600
0
0
10,200
10,600
0
0
10,600
10,500
10,600
10,600
10,600
11,000
14,500
14,700
14,900
14,400
14,400
15,800
15,100
15,100
22,400
22,500
23,000
23,600
24,200
24,500
25,200
25,500
25,700
25,500
25,400
25,400
24,900
20,000
18,800
17,939
17,575
17,512
17,447
17,449
17,478
17,398
23,737
24,036
24,444
24,678
24,475
24,675
24,862
24,769
24,489
24,611
24,728
24,843
24,955
25,390
25,488
25,576
25,667
25,753
25,911
26,014
26,117
26,590
26,907
27,209
27,353
27,224
27,495
27,428
27,193
27,317
27,465
27,640
27,748
27,905
28,044
28,222
28,370
28,548
28,641
28,818
29,040
29,288
18,135
22,479
22,775
23,088
23,315
23,693
23,983
24,375
24,634
25,067
25,161
25,658
25,916
26,375
26,582
27,277
27,894
28,599
29,421
30,261
20,640
20,803
20,940
21,075
21,126
21,283
21,441
21,599
21,727
21,917
22,167
22,330
22,482
22,608
22,721
22,938
23,107
23,280
23,396
23,575
23,781
24,057
24,193
24,370
24,458
24,859
25,047
25,344
25,631
25,871
25,87125,63125,34425,04724,85924,45824,37024,19324,05723,78123,57523,39623,28023,10722,93822,72122,60822,48222,33022,16721,91721,72721,59921,44121,28321,12621,07520,94020,80320,64030,26129,42128,59927,89427,27726,58226,37525,91625,65825,16125,06724,63424,37523,98323,69323,31523,08822,77522,47918,13529,28829,04028,81828,64128,54828,37028,22228,04427,90527,74827,64027,46527,31727,19327,42827,49527,22427,35327,20926,90726,59026,11726,01425,91125,75325,66725,57625,48825,39024,95524,84324,72824,61124,48924,76924,86224,67524,47524,67824,44424,03623,73717,39817,47817,44917,44717,51217,57517,93918,80020,00024,90025,40025,40025,50025,70025,50025,20024,50024,20023,60023,00022,50022,40015,10015,10015,80014,40014,40014,90014,70014,50011,00010,60010,60010,60010,50010,6000010,60010,200007,6006,60000004,4000003,100000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue22,098
Cost of Revenue-13,685
Gross Profit8,4138,413
 
Operating Income (+$)
Gross Profit8,413
Operating Expense-11,334
Operating Income-2,921-2,921
 
Operating Expense (+$)
Research Development1,144
Selling General Administrative7,192
Selling And Marketing Expenses2,998
Operating Expense11,33411,334
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-2,921
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,438-2,404
EBIT - interestExpense = -2,921
-3,438
-4,154
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-2,921-3,438
Earnings Before Interest and Taxes (EBITDA)-251
 
After tax Income (+$)
Income Before Tax-3,438
Tax Provision-973
Net Income From Continuing Ops-3,897-4,411
Net Income-4,154
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses25,019
Total Other Income/Expenses Net-5170
 

Technical Analysis of Psychemedics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Psychemedics. The general trend of Psychemedics is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Psychemedics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Psychemedics Corporation.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.72 < 2.72 < 2.895.

The bearish price targets are: 2.55 > 2.5 > 2.07.

Tweet this
Psychemedics Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Psychemedics Corporation. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Psychemedics Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Psychemedics Corporation. The current macd is 0.09907525.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Psychemedics price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Psychemedics. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Psychemedics price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Psychemedics Corporation Daily Moving Average Convergence/Divergence (MACD) ChartPsychemedics Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Psychemedics Corporation. The current adx is 33.24.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Psychemedics shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Psychemedics Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Psychemedics Corporation. The current sar is 2.16160557.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Psychemedics Corporation Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Psychemedics Corporation. The current rsi is 57.16. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Psychemedics Corporation Daily Relative Strength Index (RSI) ChartPsychemedics Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Psychemedics Corporation. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Psychemedics price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Psychemedics Corporation Daily Stochastic Oscillator ChartPsychemedics Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Psychemedics Corporation. The current cci is 78.52.

Psychemedics Corporation Daily Commodity Channel Index (CCI) ChartPsychemedics Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Psychemedics Corporation. The current cmo is 12.64.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Psychemedics Corporation Daily Chande Momentum Oscillator (CMO) ChartPsychemedics Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Psychemedics Corporation. The current willr is -49.15254237.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Psychemedics is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Psychemedics Corporation Daily Williams %R ChartPsychemedics Corporation Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Psychemedics Corporation.

Psychemedics Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Psychemedics Corporation. The current atr is 0.1879046.

Psychemedics Corporation Daily Average True Range (ATR) ChartPsychemedics Corporation Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Psychemedics Corporation. The current obv is -887,247.

Psychemedics Corporation Daily On-Balance Volume (OBV) ChartPsychemedics Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Psychemedics Corporation. The current mfi is 53.40.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Psychemedics Corporation Daily Money Flow Index (MFI) ChartPsychemedics Corporation Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Psychemedics Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-26ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Psychemedics Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Psychemedics Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.164
Ma 20Greater thanMa 502.453
Ma 50Greater thanMa 1002.374
Ma 100Greater thanMa 2002.294
OpenGreater thanClose2.610
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Psychemedics with someone you think should read this too:
  • Are you bullish or bearish on Psychemedics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Psychemedics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Psychemedics Corporation

I send you an email if I find something interesting about Psychemedics Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about Psychemedics Corporation.

Receive notifications about Psychemedics Corporation in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.